Ascorbic acid supplementation does not lower plasma lipoprotein(a) concentrations

Atherosclerosis

Volumn 151, Issue 2, 2000, Pages 541-544

  Jenner, Jennifer L ^a   Jacques, Paul F ^a   Seman, Leo J ^a   Schaefer, Ernst J ^a  

^a TUFTS UNIVERSITY   (United States)

Author keywords

Lipoproteins; Lp(a); Vitamin C

Indexed keywords

ASCORBIC ACID; LIPOPROTEIN A;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG BLOOD LEVEL; DRUG EFFECT; FEMALE; HUMAN; HUMAN EXPERIMENT; ISCHEMIC HEART DISEASE; LIPOPROTEIN BLOOD LEVEL; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SINGLE BLIND PROCEDURE;

ADULT; AGED; ASCORBIC ACID; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LIPOPROTEIN(A); MALE; MIDDLE AGED; OSMOLAR CONCENTRATION; REFERENCE VALUES;

EID: 0033867733     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(99)00424-4     Document Type: Article

References (17)

1. Berg K. A new serum type system in man - The Lp system. Acta. Pathol. Microbiol. Scand. 59:1963;369-382.
2. Schaefer E.J., Lamon-Fava S., Jenner J.L. et al. Lipoprotein(a) levels and risk of coronary heart disease in men: The Lipid Research Clinics Coronary Primary Prevention Trial. J. Am. Med. Assoc. 271:1994;999-1003.
3. Bostom A.G., Gagnon D.R., Cupples L.A. et al. A prospective investigation of elevated lipoprotein(a) detected by electrophoresis and cardiovascular disease in women: The Framingham Heart Study. Circulation. 90:1994;1688-1695.
4. Bostom A.G., Cupples L.A., Jenner J.L. et al. Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger. A prospective study. J. Am. Med. Assoc. 276:1996;544-548.
5. Rath M., Pauling L. Hypothesis: lipoprotein(a) is a surrogate for ascorbate. Proc. Natl. Acad. Sci. USA. 87:1990;6204-6207.
6. Rath M., Pauling L. Immunological evidence for the accumulation of lipoprotein(a) in the atherosclerotic lesion of the hypoascorbemic guinea pig. Proc. Natl. Acad. Sci. USA. 87:1990;9388-9390.
7. Jacques P.F., Sulsky S.I., Perrone G.E., Jenner J., Schaefer E.J. Effect of vitamin C supplementation on lipoprotein cholesterol, apolipoprotein, and triglyceride concentrations. Ann. Epidemiol. 5:1995;52-59.
8. Roe J.H., Keuther C.A. The determination of ascorbic acid in whole blood and urine through the 2,4-dinitrophenylhydrazine derivative de-hydro-ascorbic acid. J. Biol. Chem. 147:1943;399-403.
9. Anonymous. SPSS Reference Guide. Chicago, IL: SPSS Inc. 1990.
10. Jenner J.L., Ordovas J.M., Lamon-Fava S. et al. Effects of age, sex, and menopausal status on plasma lipoprotein(a) levels: The Framingham Offspring Study. Circulation. 87:1993;1135-1141.
11. Mensink R.P., Zock P.L., Katan M.B., Hornstra G. Effect of dietary cis and trans fatty acids on serum lipoprotein(a) levels in humans. J. Lipid. Res. 33:1992;1493-1501.
12. Bostom A.G., Hume A.L., Eaton C.B. et al. The effect of high-dose ascorbate supplementation on plasma lipoprotein(a) levels in patients with premature coronary heart disease. Pharmacotherapy. 15:1995;458-464.
13. Munoz J.A., Garcia C., Quilez J.L., Andugar M.A. Effect of vitamin C on lipoproteins in healthy adults. Ann. Med. Interne. 145:1994;13-19.
14. Maeda S., Abe A., Seishima M., Makino K., Noma A., Kawade M. Transient changes of serum lipoprotein(a) as an acute phase protein. Atherosclerosis. 78:1989;145-150.
15. Wade D.P., Clarke J.G., Lindahl G.E. et al. 5′ control regions of the apolipoprotein(a) gene and members of the related plasminogen gene family. Proc. Natl. Acad. Sci. USA. 90:1993;1369-1373.
16. Steinberg D. A critical look at the evidence for the oxidation of LDL in atherogenesis. Atherosclerosis. 131:1997;S5-S7.
17. Bendich A., Langseth L. The health effects of vitamin C supplementation: a review. J. Am. Coll. Nutr. 14:1995;124-136.